Agenus (NASDAQ:AGEN) used its first 2026 stakeholder webcast to outline operational and clinical priorities tied to its ...

Ardelyx (ARDX) rose 12% on a report that Zydus Lifesciences is in talks to purchase the company. Zydus may seek to acquire ...

Discusses Zydus Collaboration, Global Manufacturing Expansion, and Patient Access Initiatives January 28, 2026 4:00 PM ...

As cancer cases climb steadily across India, lower-cost biosimilars like Tishtha could reshape access to life-saving ...

Zydus Life may acquire Ardelyx control or buy key molecules, sources said, adding that the company is looking at raising ...

Agenus has provided Zydus with exclusive rights to develop and commercialise BOT/BAL in India and Sri Lanka.

Zydus Lifesciences Limited, an innovation-led life-sciences company with an international presence, has closed its acquisition of Agenus Inc.’s biologics manufacturing facilities.

Zydus Lifesciences share price rose in the early trade on January 27 despite the company received three observations from the ...

Zydus has also made its first overseas consumer wellness acquisition, UK-based Comfort Click, for £239 million.

Delhi High Court has cleared the way for Zydus Lifesciences to proceed with the sale of its version of the cancer drug ...

India’s Zydus Lifesciences, an innovation-led life-sciences company with an international presence, has launched the world’s first biosimilar of nivolumab in India under the brand name Tishtha, ...

Drugmakers Sun Pharma, Cipla, Zydus and Graviti Pharmaceuticals are recalling different products in the U.S., most of them over manufacturing issues.